Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ijpharm.2013.06.017
Title: Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment
Authors: Duong, H.H.P. 
Yung, L.-Y.L. 
Keywords: Doxorubicin
Dual drug synergy
FOL
Paclitaxel
TAT
Issue Date: 2013
Citation: Duong, H.H.P., Yung, L.-Y.L. (2013). Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. International Journal of Pharmaceutics 454 (1) : 486-495. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijpharm.2013.06.017
Abstract: The main purposes of this study are to demonstrate the synergistic anticancer drug systems with the combined doxorubicin (D) and paclitaxel (P) via the aid of cell penetrating and cell targeting moieties for enhancing the cancer therapeutic effect. Firstly, the synergistic effect of combined free drugs (D/P) was investigated to obtain the suitable dose combination for subsequent studies. The combination of free drugs D/P at molar ratio of 1/0.2 shows synergistic therapeutic effect compared with the treatment of a free single drug D or P. Secondly, sustainable release systems of two single drug-loaded micelles, (i) co-delivered D-FOL micelle & P-FOL micelle system and (ii) co-delivered D-TAT/FOL micelle & P-TAT/FOL micelle system, at D/P molar ratio of 1/0.2 were investigated. The results show synergistic effect with the higher efficacy of the TAT/FOL system compared to FOL only system. Finally, a dual D/P-loaded system with sustainable release rate, synergistic drug interaction, selective targeting to cancer cells and high cell penetrating ability was designed. The D/P-TAT/FOL micelles exhibit an IC50 value of 0.172 μM D/0.043 μM P, which is much lower than the IC50 values of the single drug-loaded micelles without functionalization (3.873 μM for D-micelles and 0.790 μM for P-micelles). Overall, this newly developed dual encapsulation of D and P in the multifunctional carrier would be a promising technology for cancer treatment. © 2013 Elsevier B.V. All rights reserved.
Source Title: International Journal of Pharmaceutics
URI: http://scholarbank.nus.edu.sg/handle/10635/90249
ISSN: 03785173
DOI: 10.1016/j.ijpharm.2013.06.017
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

51
checked on Nov 14, 2018

WEB OF SCIENCETM
Citations

47
checked on Nov 7, 2018

Page view(s)

35
checked on Nov 2, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.